Literature DB >> 16557594

Transcriptional profiling of MCF7 breast cancer cells in response to 5-Fluorouracil: relationship with cell cycle changes and apoptosis, and identification of novel targets of p53.

Héctor Hernández-Vargas1, Esteban Ballestar, Pedro Carmona-Saez, Cayetano von Kobbe, Inmaculada Bañón-Rodríguez, Manel Esteller, Gema Moreno-Bueno, José Palacios.   

Abstract

The availability of oral precursors of 5-Fluorouracil (5-FU) and its favorable results in treating advanced breast cancer have renewed the interest in the molecular mechanisms underlying its cytotoxicity. We have compared the changes in cell cycle and cell death parameters induced by 2 different concentrations of 5-FU (IC50 and IC80) in the breast adenocarcinoma cell line MCF7. G1/S cell cycle arrest was associated with both concentrations, whereas cell death was mainly induced after IC80 5-FU. These changes were correlated with gene expression assessed by cDNA microarray analysis. Main findings included an overexpression of p53 target genes involved in cell cycle and apoptosis (CDKN1A/p21, TP53INP, TNFRSF6/FAS and BBC3/PUMA), and significant repression of Myc. High dose 5-FU also induced a higher regulation of the mitochondrial death genes APAF1, BAK1 and BCL2, and induction of genes of the ID family. Furthermore, we establish a direct causal relationship between p21, ID1 and ID2 overexpression, increased acetylation of histones H3 and H4 and binding of p53 to their promoters as a result of 5-FU treatment. The relevance of these findings was further studied after interfering p53 expression in MCF7 cells (shp53 cells), showing a lower induction of both, ID1 and ID2 transcripts, after 5-FU when compared with MCF7 shGFP control cells. This molecular characterization of dose- and time-dependent modifications of gene expression after 5-FU treatment should provide a resource for future basic studies addressing the molecular mechanisms of chemotherapy in breast cancer. Copyright 2006 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16557594     DOI: 10.1002/ijc.21938

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  25 in total

1.  Disparate chromatin landscapes and kinetics of inactivation impact differential regulation of p53 target genes.

Authors:  Nathan P Gomes; Joaquín M Espinosa
Journal:  Cell Cycle       Date:  2010-09-13       Impact factor: 4.534

2.  Novel biochemical pathways for 5-Fluorouracil in managing experimental hepatocellular carcinoma in rats.

Authors:  Nabil M Abdel-Hamid; Mohamed A Morsy
Journal:  J Membr Biol       Date:  2010-02-23       Impact factor: 1.843

3.  Regulation of the p53 transcriptional response by structurally diverse core promoters.

Authors:  José M Morachis; Christopher M Murawsky; Beverly M Emerson
Journal:  Genes Dev       Date:  2009-12-29       Impact factor: 11.361

4.  ID1 enhances docetaxel cytotoxicity in prostate cancer cells through inhibition of p21.

Authors:  Hao Geng; Brooks L Rademacher; Janet Pittsenbarger; Chung-Ying Huang; Christopher T Harvey; Marie C Lafortune; Anne Myrthue; Mark Garzotto; Peter S Nelson; Tomasz M Beer; David Z Qian
Journal:  Cancer Res       Date:  2010-04-13       Impact factor: 12.701

Review 5.  The ID proteins: master regulators of cancer stem cells and tumour aggressiveness.

Authors:  Anna Lasorella; Robert Benezra; Antonio Iavarone
Journal:  Nat Rev Cancer       Date:  2014-01-20       Impact factor: 60.716

6.  Inhibitor of Differentiation/DNA Binding 1 (ID1) Inhibits Etoposide-induced Apoptosis in a c-Jun/c-Fos-dependent Manner.

Authors:  Yahui Zhao; Aiping Luo; Sheng Li; Wei Zhang; Hongyan Chen; Yi Li; Fang Ding; Furong Huang; Zhihua Liu
Journal:  J Biol Chem       Date:  2016-02-08       Impact factor: 5.157

7.  p53 in the mitochondria, as a trans-acting protein, provides error-correction activities during the incorporation of non-canonical dUTP into DNA.

Authors:  Elad Bonda; Galia Rahav; Angelina Kaya; Mary Bakhanashvili
Journal:  Oncotarget       Date:  2016-11-08

8.  ZBP-89 reduces the cell death threshold in hepatocellular carcinoma cells by increasing caspase-6 and S phase cell cycle arrest.

Authors:  George G Chen; Ursula P F Chan; Long-Chuan Bai; King Yip Fung; Art Tessier; Ann K Y To; Juanita L Merchant; Paul B S Lai
Journal:  Cancer Lett       Date:  2009-04-11       Impact factor: 8.679

9.  A threshold mechanism mediates p53 cell fate decision between growth arrest and apoptosis.

Authors:  M Kracikova; G Akiri; A George; R Sachidanandam; S A Aaronson
Journal:  Cell Death Differ       Date:  2013-01-11       Impact factor: 15.828

10.  ID1, inhibitor of differentiation/DNA binding, is an effector of the p53-dependent DNA damage response pathway.

Authors:  Yingjuan Qian; Xinbin Chen
Journal:  J Biol Chem       Date:  2008-06-13       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.